Loading…
Unified public record assembled from the source systems listed below. Amounts describe distinct reported activity and are not added into a single influence total.
Political giving
$0
Political receipts
$0
Lobbying income
$12,210,000
Lobbying expense
—
Federal awards
$76,575
Relationships
137
| $360,000 |
| — |
| lobbied by | 340b Working Table | $330,000 | — |
| lobbied by | Diagnostic Test Work Group (dtwg) | $320,000 | — |
| lobbied by | Diagnostic Test Work Group (dtwg) | $300,000 | — |
| lobbied by | Diagnostic Test Work Group (dtwg) | $290,000 | — |
| lobbied by | National Alliance To Impact The Social Determinants Of Health | $270,000 | — |
| lobbied by | The Dual Eligible Coalition | $250,000 | — |
| lobbied by | The Dual Eligible Coalition | $230,000 | — |
| lobbied by | The Dual Eligible Coalition | $230,000 | — |
| lobbied by | Diagnostic Test Work Group (dtwg) | $230,000 | — |
| lobbied by | The Dual Eligible Coalition | $230,000 | — |
| lobbied by | Diagnostic Test Work Group (dtwg) | $230,000 | — |
| lobbied by | Save Rare Treatments Task Force | $220,000 | — |
| lobbied by | 340b Working Table | $210,000 | Apr 20, 2026 – Jul 15, 2026 |
| lobbied by | Save Rare Treatments Task Force | $210,000 | — |
| lobbied by | Papcc Coalition | $200,000 | — |
| lobbied by | The Dual Eligible Coalition | $200,000 | — |
| lobbied by | Alliance To Modernize Prescribing Information | $190,000 | — |
| lobbied by | Sickle Cell Disease Partnership | $180,000 | — |
| lobbied by | 340b Working Table | $140,000 | — |
| lobbied by | Altamed Health Services Corporation | $140,000 | — |
| lobbied by | Llc Lundbeck Pharmaceuticals | $130,000 | — |
| lobbied by | Sickle Cell Disease Partnership | $130,000 | — |
| lobbied by | Baxter Healthcare | $110,000 | — |
| lobbied by | Antimicrobial Resistance Working Table (formerly Known As Conafay Group) | $110,000 | — |
| lobbied by | Sickle Cell Disease Partnership | $110,000 | — |
| lobbied by | Genomic Answers For Childrens Health Alliance (gacha) | $110,000 | — |
| lobbied by | Baxter Healthcare | $110,000 | — |
| lobbied by | Baxter Healthcare | $100,000 | — |
| lobbied by | The Dual Eligible Coalition | $100,000 | — |
| lobbied by | Alliance For Mrna Medicines | $100,000 | Apr 20, 2026 – Jul 15, 2026 |
| lobbied by | Genomic Answers For Childrens Health Alliance (gacha) | $90,000 | — |
| lobbied by | Save Rare Treatments Task Force | $90,000 | Apr 20, 2026 – Jul 15, 2026 |
| lobbied by | Sickle Cell Disease Partnership | $90,000 | Apr 20, 2026 – Jul 15, 2026 |
| lobbied by | The Individual Market Coalition (imc) | $90,000 | — |
| lobbied by | The Enrollment Coalition | $90,000 | — |
| lobbied by | Alliance For Mrna Medicines | $90,000 | — |
| lobbied by | Baxter Healthcare | $90,000 | — |
| lobbied by | Llc Lundbeck Pharmaceuticals | $90,000 | — |
| lobbied by | Baxter Healthcare | $80,000 | — |
| lobbied by | Baxter Healthcare | $80,000 | — |
| lobbied by | Baxter Healthcare | $80,000 | — |
| lobbied by | Baxter Healthcare | $80,000 | — |
| lobbied by | Ddusa | $80,000 | — |
| lobbied by | Baxter Healthcare | $80,000 | — |
| lobbied by | Baxter Healthcare | $80,000 | — |
| lobbied by | The Compounding Quality Coalition | $80,000 | — |